The paclitaxel files – reasonable doubt or acquittal?

References

• 1 Seiffert M, Brunner FJ, Remmel M, Thomalla G, Marschall U, L’Hoest H, et al. Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany – An analysis of health insurance claims. Clin Res Cardiol. 2020;109:1540–8. First citation in articleCrossref Medline, Google Scholar

• 2 Mills JL, Conte MS, Murad MH. Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease. J Vasc Surg. 2019;70:3–7. First citation in articleCrossref Medline, Google Scholar

• 3 Zeller T, Noory E, Beschorner U, Böhme T, Reijnen MMPJ. Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic. VASA. 2019;48:109–11. First citation in articleLink, Google Scholar

• 4 Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. JAHA. 2018;7:e011245. First citation in articleCrossref, Google Scholar

• 5 Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Paraskevopoulos I, Karnabatidis D. Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2020;31:202–12. First citation in articleCrossref Medline, Google Scholar

• 6 Rocha-Singh KJ, Duval S, Jaff MR, Schneider PA, Ansel GM, Lyden SP, et al. Mortality and paclitaxel-coated devices. Circulation. 2020;141:1859–69. First citation in articleCrossref Medline, Google Scholar

• 7 Dinh K, Gomes ML, Thomas SD, Paravastu SCV, Holden A, Schneider PA, et al. Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischemia: a systematic review and meta-analysis of randomized controlled trials. Journal of Endovascular Therapy. 2020;27:17585. First citation in articleCrossref, Google Scholar

• 8 Schneider PA, Laird JR, Doros G, Gao Q, Ansel G, Brodmann M, et al. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. Journal of the American College of Cardiology. 2019;73:2550–63. First citation in articleCrossref Medline, Google Scholar

• 9 Böhme T, Noory E, Beschorner U, Jacques B, Bürgelin K, Macharzina R, et al. Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in patients with ulcerations and gangrene - a single center experience. VASA. 2021;50:132–138. First citation in articleAbstract, Google Scholar

• 10 Kaschwich M, Peters F, Hischke S, Rieß HC, Gansel M, Marschall U, et al. Long-term incidence of cancer after index treatment for symptomatic peripheral arterial occlusive disease – A health insurance claims data analysis. VASA. 2020;49:493–9. First citation in articleLink, Google Scholar

• 11 Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, et al. Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA Cardiol. 2019;4:332–40. First citation in articleCrossref Medline, Google Scholar

• 12 Behrendt CA, Sedrakyan A, Peters F, Kreutzburg T, Schermerhorn M, Bertges DJ, et al. Editor’s Choice - long term survival after femoropopliteal artery revascularizations with paclitaxel-coated devices – a propensity score matched cohort analysis. Eur J Vasc Endovasc Surg. 2020;59:587–96. First citation in articleCrossref Medline, Google Scholar

• 13 Heidemann F, Peters F, Kuchenbecker J, Kreutzburg T, Sedrakyan A, Marschall U, et al. Long-term outcomes after revascularizations below the knee with paclitaxel-coated devices – a propensity score matched cohort analysis. Eur J Vasc Endovasc Surg. 2020;60:549–58. First citation in articleCrossref Medline, Google Scholar

• 14 Saratzis A, Lea T, Yap T, Batchelder A, Thomson B, Saha P, et al. Paclitaxel and mortality following peripheral angioplasty: an adjusted and case matched multicentre analysis. Eur J Vasc Endovasc Surg. 2020;60:220–29. First citation in articleCrossref Medline, Google Scholar

• 15 Behrendt CA, Peters F, Mani K, The swinging pendulum of evidence – Is there a reality behind results from randomized trials and real-world data? Lessons learned from the Paclitaxel debate. Eur J Vasc Endovasc Surg. 2020;59:510–1. First citation in articleCrossref Medline, Google Scholar